| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f698316e6b4f5119b84446571303b7b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 |
| filingDate |
1999-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93ffb5da79bd9160fc164b3721943903
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b33cbf14c138be2f68a487c5b2b511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32dacc0f1cf5482a72ad1c59e2f5c5b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e34c1fb841342f2efa3c2f07278a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60d2849d11f4fe8ddd72ecf0cb0fcc1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86302210dbe445e128a8eaba251633c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffd21195659ccada3c7b8181b8a1f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cea92ac5d87fac20417acd160a3b0f54 |
| publicationDate |
2004-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1121929-B1 |
| titleOfInvention |
Composition comprising di- and trisodiumsalts of echinochrome for treating ocular conditions |
| abstract |
A pharmaceutical composition is provided which comprises an isotonic solution of an 0.02% mixture of di- and trisodim salts of echinochrome (Histochrome). It meets the requirements that apply to injectable formulations. Histochrome administration to human patients normalizes metabolic processes and eliminates inflammation in the retina, vascular membrane and cornea of the eye, improves trophic functions, reduces edema and accelerates epithelization. |
| priorityDate |
1998-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |